医学
危险系数
中期分析
外科
胃切除术
临床终点
癌症
阶段(地层学)
淋巴结切除术
随机对照试验
化疗
内科学
置信区间
生物
古生物学
作者
Mitsuru Sasako,Shinichi Sakuramoto,Hitoshi Katai,Taira Kinoshitá,Hiroshi Furukawa,Toshiharu Yamaguchi,Atsushi Nashimoto,Masashi Fujii,Toshifusa Nakajima,Yasuo Ohashi
标识
DOI:10.1200/jco.2011.36.5908
摘要
On the basis of 5-year follow-up data, postoperative adjuvant therapy with S-1 was confirmed to improve overall survival and relapse-free survival in patients with stage II or III gastric cancer who had undergone D2 gastrectomy.
科研通智能强力驱动
Strongly Powered by AbleSci AI